BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Katsarou MS, Papasavva M, Latsi R, Toliza I, Gkaros AP, Papakonstantinou S, Gatzonis S, Mitsikostas DD, Kovatsi L, Izotov BN, Tsatsakis AM, Drakoulis N. Population-Based Analysis of Cluster Headache-Associated Genetic Polymorphisms. J Mol Neurosci 2018;65:367-76. [PMID: 29959630 DOI: 10.1007/s12031-018-1103-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Siokas V, Kardaras D, Aloizou AM, Asproudis I, Boboridis KG, Papageorgiou E, Spandidos DA, Tsatsakis A, Tsironi EE, Dardiotis E. Lack of Association of the rs11655081 ARSG Gene with Blepharospasm. J Mol Neurosci 2019;67:472-6. [PMID: 30656493 DOI: 10.1007/s12031-018-1255-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
2 Katsarou MS, Sidiropoulou P, Ieronymaki D, Mastraftsi S, Sifaki M, Xenos K, Nosyrev A, Kovatsi L, Spandidos DA, Lagiou M, Dagklis C, Gregoriou S, Tagka A, Rigopoulos D, Drakoulis N, Nicolaidou E. Impact of vitamin D receptor gene polymorphisms on vitiligo susceptibility and clinical features in a Southeastern European Caucasian population. Int J Mol Med 2020;46:1899-907. [PMID: 33000207 DOI: 10.3892/ijmm.2020.4732] [Reference Citation Analysis]
3 Stamati P, Siokas V, Aloizou A, Karampinis E, Arseniou S, Rakitskii VN, Tsatsakis A, Spandidos DA, Gozes I, Mitsias PD, Bogdanos DP, Hadjigeorgiou GM, Dardiotis E. Does SCFD1 rs10139154 Polymorphism Decrease Alzheimer’s Disease Risk? J Mol Neurosci 2019;69:343-50. [DOI: 10.1007/s12031-019-01363-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
4 Yang J, Yu SY, Yang J, Kong J, Liang FR, Lv ZT. No Association Between G1246A Polymorphism in HCRTR2 Gene and Risk of Cluster Headache: Evidence From an Updated Meta-Analysis of Observational Studies. Front Genet 2020;11:560517. [PMID: 33343621 DOI: 10.3389/fgene.2020.560517] [Reference Citation Analysis]
5 Cacabelos R. Pharmacogenomics of drugs used to treat brain disorders. Expert Review of Precision Medicine and Drug Development 2020;5:181-234. [DOI: 10.1080/23808993.2020.1738217] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
6 Papasavva M, Katsarou MS, Vikelis M, Mitropoulou E, Dermitzakis EV, Papakonstantinou S, Arvaniti C, Mitsikostas DD, Gozes I, Tsatsakis AM, Drakoulis N. Analysis of HCRTR2, GNB3, and ADH4 Gene Polymorphisms in a Southeastern European Caucasian Cluster Headache Population. J Mol Neurosci 2020;70:467-74. [PMID: 31768945 DOI: 10.1007/s12031-019-01439-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]